Fulcrum Therapeutics FULC reported its Q4 earnings results on Thursday, March 3, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Fulcrum Therapeutics beat estimated earnings by 20.55%, reporting an EPS of $-0.58 versus an estimate of $-0.73.
Revenue was up $833.00 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.08 which was followed by a 5.39% drop in the share price the next day.
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.